Kalinsky E, Prat F, Boyer J, Pelletier G, Fritsch J, Choury A D, Person B, Buffet C
Service d'Hépato-Gastroentérologie, CHU Bicêtre, Paris.
Gastroenterol Clin Biol. 1999 Feb;23(2):187-94.
The hydrostatic dilatation of the papilla of Vater, or sphincteroclasy, has been recently proposed as an alternative to endoscopic sphincterotomy. Our aim was to assess short term results and follow-up after sphincteroclasy for choledocholithiasis.
From August, 1994 to December, 1996, 52 patients were included for endoscopic therapy of choledocholithiasis (mean age 66 +/- 17 years). Patients were prospectively followed on the short term-period (24 h, 48 h and 30 days) and longer term after treatment (every 6 months) by clinical and biological controls.
Forty-eight sphincteroclasies were performed successfully (92.3%). Thirty seven patients had a choledocolithiasis. Eleven were stone-free. Eight had undergone former gastric surgery and 8 had impaired coagulation test. Complete stone clearance was achieved in 98% of patients. Mild pancreatitis were observed in three patients (6.25%). Thirty-day mortality was nil. Long term follow-up (mean 21.4 +/- 7 months) revealed: 2 patients with cholecystitis 6 and 13 months after treatment, one of which was followed 8 months later by a fatal septic shock, and 3 patients with cholangitis, 2 of which in the same patient, 9, 12 and 24 months after sphincteroclasy. The global long term biliary complication rate was 8.4%, 4.2% of which were potentially related to the endoscopic procedure.
Sphincteroclasy is an efficient procedure for the treatment of choledocholithiasis. Its short term results are similar to those of endoscopic sphincterotomy. Complications after 2 years appear to be scarce, but longer follow-up is required before routinely performing sphincteroclasy.
最近有人提出采用 Vater 壶腹的液压扩张术,即括约肌切开术,作为内镜括约肌切开术的替代方法。我们的目的是评估括约肌切开术治疗胆总管结石的短期结果和随访情况。
1994 年 8 月至 1996 年 12 月,52 例患者纳入胆总管结石的内镜治疗(平均年龄 66±17 岁)。通过临床和生物学检查对患者进行前瞻性短期(24 小时、48 小时和 30 天)及治疗后长期(每 6 个月)随访。
成功进行了 48 例括约肌切开术(92.3%)。37 例患者患有胆总管结石。11 例结石清除。8 例曾接受过胃部手术,8 例凝血试验异常。98%的患者结石完全清除。3 例患者出现轻度胰腺炎(6.25%)。30 天死亡率为零。长期随访(平均 21.4±7 个月)显示:2 例患者在治疗后 6 个月和 13 个月发生胆囊炎,其中 1 例在 8 个月后死于感染性休克,3 例患者发生胆管炎,其中 2 例为同一患者,分别在括约肌切开术后 9 个月、12 个月和 24 个月发生。总体长期胆道并发症发生率为 8.4%,其中 4.2%可能与内镜操作有关。
括约肌切开术是治疗胆总管结石的有效方法。其短期结果与内镜括约肌切开术相似。2 年后的并发症似乎较少,但在常规进行括约肌切开术之前还需要更长时间的随访。